Director, Value & Access

Director, Value & Access

United Kingdom - Uxbridge Market Access & Health Economics Regular

Director, Global Value & Access Oncology Execution – non-EU ex-US markets (Stockley Park, UK / Foster City, USA). This role supports Oncology Value & Access activities in non-European ex-US markets, and local access. It requires close collaboration with cross-functional teams to execute global Value & Access strategies and launch plans for Gilead Oncology brands in alignment with commercial/medical and country market access colleagues.

Initial focus on in-line and upcoming indications in breast cancer.

At Gilead, we are driven to develop lifesaving products that make a difference for patients around the world. Every day, we strive to transform the promise of science and technology into breakthrough, innovative therapies that have the power to cure, prevent or treat disease. As a research-based biopharmaceutical company, we are revolutionizing healthcare by bringing medicines to patients in the areas of unmet need including HIV, AIDS, liver diseases, oncology, inflammation and respiratory diseases.

When you join Gilead, you join our mission to change the world, by enabling people to live healthier and more fulfilling lives.

Making an impact on a global scale

Gilead's mission is to discover, develop, and deliver therapies that will improve the lives of patients with life-threatening illnesses worldwide.

In this role, you will be responsible for supporting Oncology Value & Access activities in non-European ex-US markets, as well as local access. Critical to the success of this role is the ability to work closely with cross-functional colleagues to execute global V&A strategies and launch plans for Gilead Oncology brands in alignment with commercial/medical and country market access colleagues. The role scope covers the entire Gilead Oncology franchise, with initial focus on in-line and upcoming indications in breast cancer.

You will be the voice of the relevant markets feeding their needs into the development of Global strategy and materials to maximize product potential and access.

Key Responsibilities

• Establish and shape new affiliate engagement model, with expanded scope of responsibility for Oncology Execution Leads (now incorporating four core markets: Australia, Canada, China and Japan)
• Cultivate close working relationships with local V&A representatives globally and develop a deep understanding of their local access environment and resultant needs
• Partner with local market teams to adapt and drive execution of GV&A strategies and launch plans to optimize access, reimbursement and uptake of Oncology franchise products (initial focus on Trodelvy), aligned to local needs
• Partner with global cross-functional teams to develop and implement awareness of unmet needs, Oncology product value propositions and health economics tools to support value demonstration and differentiation
• Collaborate with the GV&A Capabilities & Execution Strategy Lead to roll out the Value Shaping & Realisation initiative for local market readiness
• Support V&A stakeholder engagement plans across local market affiliates, develop engagement objectives and tools to monitor activities and KPIs
• Support payer research and insights generation (as needed) to understand Oncology product value perception, V&A landscape trends, value drivers and test value messages
• Provide non-EU ex-US market perspective and champion local markets’ needs into development of GV&A strategies and materials
• Lead Worldwide Trodelvy V&A Community monthly meetings to ensure efficient communication and knowledge sharing with all affiliates

We’re seeking a strategic, influential leader with the following:

• At least 12+ years’ experience in the biotech or pharmaceutical industry in market access-related activities with a Bachelors degree OR 10+ years’ experience with a MS/MA OR 8+ years’ experience with a PhD.
• Experience in regional/country-level market access, launch planning and execution required; global (above-country) experience preferred but not essential.
• Oncology disease area experience and market…